BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights, analysis and consulting, announced today that John Ho, M.D., has joined the company as President of Decision Resources Consulting. Dr. Ho comes to Decision Resources Group from Charles River Laboratories, a leading CRO (Contract Research Organization), where he led the corporate strategy and business development activities. Previous to this, he spent nearly 20 years in senior level roles within the management consulting industry. His experience spans being the Global Early Development Partner in Accenture’s Life Sciences Pharmaceutical Practice and a Partner in Pittiglio, Rabbin, Todd and McGrath’s (PRTM) Pharmaceutical and Medical Device Practice. Prior to this, he was a Senior Engagement Manager at McKinsey & Company.
Dr. Ho will be responsible for managing and expanding Decision Resources Group’s Consulting division by leveraging the organization’s significant, and growing, intellectual capital and organizational resources.
“There is a great deal of opportunity in the consulting environment to leverage our company’s deep therapeutic, device and managed markets intellectual property,” said Sarah Fuller, President of Decision Resources Group. “Fueled by his extensive experience, John will bring much more visibility and luster to our consulting business that spans all our company brands. He’s a great and very welcome addition to our senior management team.”
“I am excited to join this distinguished organization,” said Dr. Ho. “Decision Resources Group has been a longtime leader in providing in-depth analytics, data and advisory services to the biopharma industry and I am pleased to join on as it continues to grow. I look forward to making the industry more broadly aware of the distinctive and unique capabilities of our consulting organization and providing even greater value and impact to our many valued clients.”
Dr. Ho received his M.B.A. from the Amos Tuck School at Dartmouth, an M.D. from Brown University School of Medicine and a B.S. in Biology and Molecular Genetics from Massachusetts Institute of Technology. In addition, he did post graduate medical training at the Beth Israel New England Deaconess Hospital, part of the Harvard Medical School community.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, insights, advisory services and consulting on important sectors of the healthcare industry. Clients rely on this analysis, data and consulting services to make more informed critical management decisions. With over 450 employees worldwide, analysts at Decision Resources Group companies provide the pharmaceutical, biotech, medical device, financial services and managed care industries with the analytics and advice they need to compete and thrive in an increasingly competitive marketplace. Through both organic growth and an aggressive acquisition strategy, Decision Resources Group has become the premier provider of healthcare analysis, data and consulting in the world. Visit Decision Resources Group at www.DecisionResourcesGroup.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.